Amelioration of cisplatin-induced nephrotoxicity in peroxiredoxin I-deficient mice

c-MYC Suppresses BIN1 to Release Poly(ADP-Ribose) Polymerase 1: A Mechanism by Which Cancer Cells Acquire Cisplatin Resistance

(2011) S. Pyndiah et al.   Science Signaling

Transcriptional Regulation of Renal Cytoprotective Genes by Nrf2 and Its Potential Use as a Therapeutic Target to Mitigate Cisplatin-Induced Nephrotoxicity

(2010) L. M. Aleksunes et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

c-Myc Amplification Altered the Gene Expression of ABC- and SLC-Transporters in Human Breast Epithelial Cells

(2009) Keon Wook Kang et al.   MOLECULAR PHARMACEUTICS

Peroxiredoxin I plays a protective role against cisplatin cytotoxicity through mitogen activated kinase signals

(2009) Dongmei Ma et al.   ORAL ONCOLOGY

Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice

(2008) Kosuke Okada et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies

(2008) N. Pabla et al.   KIDNEY INTERNATIONAL

Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment

(2008) Lauren M. Aleksunes et al.   TOXICOLOGY